Evans Ronald M 4
4 · Metacrine, Inc. · Filed Sep 22, 2020
Insider Transaction Report
Form 4
Metacrine, Inc.MTCR
Evans Ronald M
Director
Transactions
- Conversion
Series A Convertible Preferred Stock
2020-09-18−9,803→ 0 total(indirect: See footnote)→ Common Stock (9,803 underlying) - Conversion
Common Stock
2020-09-18+9,803→ 9,803 total(indirect: See footnote)
Holdings
- 424,693
Common Stock
Footnotes (2)
- [F1]Every 5.1 shares of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (the "Preferred Stock") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering. Share numbers give effect to such conversion. The Preferred Stock had no expiration date.
- [F2]Evans Potter Rev. Trust 12/29/1989